Nanion Technologies and NEXEL partner to open a new reference demonstration laboratory in South Korea
(PresseBox) - April 17th 2020: Nanion Technologies GmbH, a leading provider of automated patch clamp and cell monitoring systems, announces the partnership with NEXEL Co., Ltd., specialists in the manufacturing of hiPSC-derived cells. Under the partnership NEXEL will provide demonstration infrastructure in South Korea for Nanion
Nanion Technologies and NEXEL are pleased to announce a partnership, focused on combining Nanion?s CardioExcyte 96 and FLEXcyte 96 cell monitoring technology with NEXEL?s hiPSC-derived cells for demonstration purposes. Bringing together the two companies? infrastructure and expertise serves to meet the growing demand for a reliable, high throughput cell monitoring technology in Asia.
The Nanion-NEXEL partnership brings together profound skills in comprehensive in vitro electrophysiology technology and development of human induced pluripotent stem cells (hiPSCs), with focus on
Dr. Choong-Seong Han, CEO of Nexel, says: ?Nexel is proud to start this partnership with Nanion Technologies. We believe it will further build on the excellent relationship we have developed together in the last year. The Cardiosightll increase with our collaborative efforts.?
The CardioExcyte 96 and its add-on FLEXcyte 96 enable a comprehensive analysis of viability, contractility and electrophysiology of cardiomyocyte networks under physiological conditions. This allows diverse assay applications, such as safety pharmacology, basic cardiotox assays and drug discovery assays. In addition, FLEXcyte 96 offers recordings on flexible substrates which allow monitoring true contractility under physiological conditions.
Frank Henrichsen, Director of Global Sales of Nanion Technologies
About NEXEL:
NEXEL, Co., Ltd. is a bio-company that was incorporated in 2012 with proprietary stem cell technologies. Their philosophy is to ?make a better place? by supporting innovative research around the globe by providing high quality stem cell-derived cell products.
NEXEL, Co., Ltd. launched the CardiosightioExcyte 96.
Other product lines include the Hepatosight
Nanion Technologies is a leading provider of instrumentation for ion channel drug discovery and screening. Founded in 2002, Nanion has grown over the last 18 years to a company with over 100 employees worldwide. With headquarters in Munich, Germany, Nanion has subsidiaries in the USA, Japan, China and Denmark, as well as distribution partners in seven other countries.
Nanion?s team has developed and successfully established four generations of automated patch clamp instruments for sophisticated and high throughput applications in ion channel research and drug discovery (Port-a-Patch, Patchliner and SyncroPatch product families).
Further product lines are for cell monitoring and cardiotoxicity screening (CardioExcyte 96/FLEXcyte 96), for parallel bilayer recordings (Orbit family), and for parallel membrane transporter protein recordings (SURFE
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Nanion Technologies is a leading provider of instrumentation for ion channel drug discovery and screening. Founded in 2002, Nanion has grown over the last 18 years to a company with over 100 employees worldwide. With headquarters in Munich, Germany, Nanion has subsidiaries in the USA, Japan, China and Denmark, as well as distribution partners in seven other countries.Nanion?s team has developed and successfully established four generations of automated patch clamp instruments for sophisticated and high throughput applications in ion channel research and drug discovery (Port-a-Patch, Patchliner and SyncroPatch product families).Further product lines are for cell monitoring and cardiotoxicity screening (CardioExcyte 96/FLEXcyte 96), for parallel bilayer recordings (Orbit family), and for parallel membrane transporter protein recordings (SURFE²R).
Datum: 17.04.2020 - 11:22 Uhr
Sprache: Deutsch
News-ID 1557510
Anzahl Zeichen: 4853
contact information:
Contact person:
Town:
München
Phone:
Kategorie:
Handcrafts
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 1594 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Nanion Technologies and NEXEL partner to open a new reference demonstration laboratory in South Korea
"
steht unter der journalistisch-redaktionellen Verantwortung von
Nanion Technologies GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
